Hadassah

Hadassah’s Head of Pediatrics Receives Honorary Fellowship from Royal College of Pediatrics

Tuesday, Jun 28 2016

The Center for Children with Chronic Diseases.

Prof. Eitan Kerem, head of the Division of Pediatrics at the Hadassah Medical Center, Founder of its Center for Children with Chronic Diseases, and world-renowned specialist in cystic fibrosis (CF), has been awarded an Honorary Fellowship from the United Kingdom’s Royal College of Pediatrics and Child Health “in recognition of his outstanding contributions to the objectives of the College.” Royal College’s mission is to transform child health through knowledge, innovation, and expertise.

In 2014, Prof. Kerem received the prestigious European Cystic Fibrosis Society’s prize for his outstanding work in CF.

As stated by the Royal College: “Prof. Kerem has advanced child health through his work in partnership with the Palestinian community, through his pioneering work in cystic fibrosis, and his indefatigable labors for the rights of all children. His true excellence lies in his humanitarian contribution, as he has a proven record of building bridges between Israelis and Palestinians, furthering peace through medicine wherever possible, and raising the standards of health care delivery in both communities. He has been active in training Palestinian pediatricians in his cystic fibrosis clinic, and treating Palestinian children.

“Prof. Kerem is a world-known leader in cystic fibrosis research, serving as a principal investigator of many national and international clinical trials and author of key publications in the field. He was the first to demonstrate that gentamicin over-rode premature stop codons. He was also involved in formulating the guidelines that paved the road to the standardization of CF care in Europe and other parts of the world. He is a recipient of the prestigious Ordine Della Stella Della Solidarieta ltaliana Award. The European Cystic Fibrosis Society recently recognized Prof. Kerem for his vast interest in cystic fibrosis across all aspects b

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More